The RING-CH Ligase K5 Antagonizes Restriction of KSHV and HIV-1 Particle Release by Mediating Ubiquitin-Dependent Endosomal Degradation of Tetherin


Tetherin (CD317/BST2) is an interferon-induced membrane protein that inhibits the release of diverse enveloped viral particles. Several mammalian viruses have evolved countermeasures that inactivate tetherin, with the prototype being the HIV-1 Vpu protein. Here we show that the human herpesvirus Kaposi's sarcoma-associated herpesvirus (KSHV) is sensitive to tetherin restriction and its activity is counteracted by the KSHV encoded RING-CH E3 ubiquitin ligase K5. Tetherin expression in KSHV-infected cells inhibits viral particle release, as does depletion of K5 protein using RNA interference. K5 induces a species-specific downregulation of human tetherin from the cell surface followed by its endosomal degradation. We show that K5 targets a single lysine (K18) in the cytoplasmic tail of tetherin for ubiquitination, leading to relocalization of tetherin to CD63-positive endosomal compartments. Tetherin degradation is dependent on ESCRT-mediated endosomal sorting, but does not require a tyrosine-based sorting signal in the tetherin cytoplasmic tail. Importantly, we also show that the ability of K5 to substitute for Vpu in HIV-1 release is entirely dependent on K18 and the RING-CH domain of K5. By contrast, while Vpu induces ubiquitination of tetherin cytoplasmic tail lysine residues, mutation of these positions has no effect on its antagonism of tetherin function, and residual tetherin is associated with the trans-Golgi network (TGN) in Vpu-expressing cells. Taken together our results demonstrate that K5 is a mechanistically distinct viral countermeasure to tetherin-mediated restriction, and that herpesvirus particle release is sensitive to this mode of antiviral inhibition.


Vyšlo v časopise: The RING-CH Ligase K5 Antagonizes Restriction of KSHV and HIV-1 Particle Release by Mediating Ubiquitin-Dependent Endosomal Degradation of Tetherin. PLoS Pathog 6(4): e32767. doi:10.1371/journal.ppat.1000843
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1000843

Souhrn

Tetherin (CD317/BST2) is an interferon-induced membrane protein that inhibits the release of diverse enveloped viral particles. Several mammalian viruses have evolved countermeasures that inactivate tetherin, with the prototype being the HIV-1 Vpu protein. Here we show that the human herpesvirus Kaposi's sarcoma-associated herpesvirus (KSHV) is sensitive to tetherin restriction and its activity is counteracted by the KSHV encoded RING-CH E3 ubiquitin ligase K5. Tetherin expression in KSHV-infected cells inhibits viral particle release, as does depletion of K5 protein using RNA interference. K5 induces a species-specific downregulation of human tetherin from the cell surface followed by its endosomal degradation. We show that K5 targets a single lysine (K18) in the cytoplasmic tail of tetherin for ubiquitination, leading to relocalization of tetherin to CD63-positive endosomal compartments. Tetherin degradation is dependent on ESCRT-mediated endosomal sorting, but does not require a tyrosine-based sorting signal in the tetherin cytoplasmic tail. Importantly, we also show that the ability of K5 to substitute for Vpu in HIV-1 release is entirely dependent on K18 and the RING-CH domain of K5. By contrast, while Vpu induces ubiquitination of tetherin cytoplasmic tail lysine residues, mutation of these positions has no effect on its antagonism of tetherin function, and residual tetherin is associated with the trans-Golgi network (TGN) in Vpu-expressing cells. Taken together our results demonstrate that K5 is a mechanistically distinct viral countermeasure to tetherin-mediated restriction, and that herpesvirus particle release is sensitive to this mode of antiviral inhibition.


Zdroje

1. HallerO

KochsG

WeberF

2006 The interferon response circuit: induction and suppression by pathogenic viruses. Virology 344 119 130

2. WolfD

GoffSP

2008 Host restriction factors blocking retroviral replication. Annu Rev Genet 42 143 163

3. NeilS

BieniaszP

2009 Human immunodeficiency virus, restriction factors, and interferon. J Interferon Cytokine Res 29 569 580

4. MalimMH

EmermanM

2008 HIV-1 accessory proteins–ensuring viral survival in a hostile environment. Cell Host Microbe 3 388 398

5. NeilSJ

ZangT

BieniaszPD

2008 Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451 425 430

6. Van DammeN

GoffD

KatsuraC

JorgensonRL

MitchellR

2008 The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3 245 252

7. NeilSJ

EastmanSW

JouvenetN

BieniaszPD

2006 HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane. PLoS Pathog 2 e39 doi:10.1371/journal.ppat.0020039

8. NeilSJ

SandrinV

SundquistWI

BieniaszPD

2007 An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein. Cell Host Microbe 2 193 203

9. JouvenetN

NeilSJ

ZhadinaM

ZangT

KratovacZ

2009 Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J Virol 83 1837 1844

10. Perez-CaballeroD

ZangT

EbrahimiA

McNattMW

GregoryDA

2009 Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 139 499 511

11. KupzigS

KorolchukV

RollasonR

SugdenA

WildeA

2003 Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic 4 694 709

12. SakumaT

NodaT

UrataS

KawaokaY

YasudaJ

2009 Inhibition of Lassa and Marburg virus production by tetherin. J Virol 83 2382 2385

13. KaletskyRL

FrancicaJR

Agrawal-GamseC

BatesP

2009 Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc Natl Acad Sci U S A 106 2886 2891

14. BlasiusAL

GiurisatoE

CellaM

SchreiberRD

ShawAS

2006 Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J Immunol 177 3260 3265

15. KawaiS

AzumaY

FujiiE

FurugakiK

OzakiS

2008 Interferon-alpha enhances CD317 expression and the antitumor activity of anti-CD317 monoclonal antibody in renal cell carcinoma xenograft models. Cancer Sci 99 2461 2466

16. OhtomoT

SugamataY

OzakiY

OnoK

YoshimuraY

1999 Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells. Biochem Biophys Res Commun 258 583 591

17. MiyagiE

AndrewAJ

KaoS

StrebelK

2009 Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion. Proc Natl Acad Sci U S A 106 2868 2873

18. McNattMW

ZangT

HatziioannouT

BartlettM

FofanaIB

2009 Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants. PLoS Pathog 5 e1000300 doi:10.1371/journal.ppat.1000300

19. GuptaRK

HueS

SchallerT

VerschoorE

PillayD

2009 Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion. PLoS Pathog 5 e1000443 10.1371/journal.ppat.1000443

20. LehnerPJ

HoerS

DoddR

DuncanLM

2005 Downregulation of cell surface receptors by the K3 family of viral and cellular ubiquitin E3 ligases. Immunol Rev 207 112 125

21. StevensonPG

EfstathiouS

DohertyPC

LehnerPJ

2000 Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses. Proc Natl Acad Sci U S A 97 8455 8460

22. CoscoyL

GanemD

2000 Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc Natl Acad Sci U S A 97 8051 8056

23. IshidoS

WangC

LeeBS

CohenGB

JungJU

2000 Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J Virol 74 5300 5309

24. CoscoyL

GanemD

2001 A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation. J Clin Invest 107 1599 1606

25. MansouriM

DouglasJ

RosePP

GouveiaK

ThomasG

2006 Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells. Blood 108 1932 1940

26. ThomasM

BonameJM

FieldS

NejentsevS

SalioM

2008 Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity. Proc Natl Acad Sci U S A 105 1656 1661

27. LiQ

MeansR

LangS

JungJU

2007 Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 and K5. J Virol 81 2117 2127

28. BarteeE

McCormackA

FruhK

2006 Quantitative membrane proteomics reveals new cellular targets of viral immune modulators. PLoS Pathog 2 e107 doi:10.1371/journal.ppat.0020107

29. MettenleiterTC

KluppBG

GranzowH

2006 Herpesvirus assembly: a tale of two membranes. Curr Opin Microbiol 9 423 429

30. VieiraJ

O'HearnPM

2004 Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. Virology 325 225 240

31. YlinenLM

KeckesovaZ

WilsonSJ

RanasingheS

TowersGJ

2005 Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5alpha alleles. J Virol 79 11580 11587

32. Le TortorecA

NeilSJ

2009 Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein. J Virol 83 11966 11978

33. JiaB

Serra-MorenoR

NeidermyerW

RahmbergA

MackeyJ

2009 Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog 5 e1000429 doi:10.1371/journal.ppat.1000429

34. GoffinetC

AllespachI

HomannS

TervoHM

HabermannA

2009 HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor. Cell Host Microbe 5 285 297

35. MangeatB

Gers-HuberG

LehmannM

ZuffereyM

LubanJ

2009 HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation. PLoS Pathog 5 e1000574 doi:10.1371/journal.ppat.1000574

36. DouglasJL

ViswanathanK

McCarrollMN

GustinJK

FruhK

2009 Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism. J Virol 83 7931 7947

37. MitchellRS

KatsuraC

SkaskoMA

FitzpatrickK

LauD

2009 Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking. PLoS Pathog 5 e1000450 doi:10.1371/journal.ppat.1000450

38. DuncanLM

PiperS

DoddRB

SavilleMK

SandersonCM

2006 Lysine-63-linked ubiquitination is required for endolysosomal degradation of class I molecules. EMBO J 25 1635 1645

39. GuptaRK

MlcochovaP

Pelchen-MatthewsA

PetitSJ

MattiuzzoG

2009 Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration. Proc Natl Acad Sci U S A

40. RollasonR

KorolchukV

HamiltonC

SchuP

BantingG

2007 Clathrin-mediated endocytosis of a lipid-raft-associated protein is mediated through a dual tyrosine motif. J Cell Sci 120 3850 3858

41. HewittEW

DuncanL

MuftiD

BakerJ

StevensonPG

2002 Ubiquitylation of MHC class I by the K3 viral protein signals internalization and TSG101-dependent degradation. EMBO J 21 2418 2429

42. HurleyJH

2008 ESCRT complexes and the biogenesis of multivesicular bodies. Curr Opin Cell Biol 20 4 11

43. WollertT

WunderC

Lippincott-SchwartzJ

HurleyJH

2009 Membrane scission by the ESCRT-III complex. Nature 458 172 177

44. Martin-SerranoJ

EastmanSW

ChungW

BieniaszPD

2005 HECT ubiquitin ligases link viral and cellular PPXY motifs to the vacuolar protein-sorting pathway. J Cell Biol 168 89 101

45. ZhangF

WilsonSJ

LandfordWC

VirgenB

GregoryD

2009 Nef Proteins from Simian Immunodeficiency Viruses Are Tetherin Antagonists. Cell Host Microbe

46. MansouriM

ViswanathanK

DouglasJL

HinesJ

GustinJ

2009 Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus. J Virol 83 9672 9681

47. HaqueM

ChenJ

UedaK

MoriY

NakanoK

2000 Identification and analysis of the K5 gene of Kaposi's sarcoma-associated herpesvirus. J Virol 74 2867 2875

48. DubeM

RoyBB

Guiot-GuillainP

MercierJ

BinetteJ

2009 Suppression of Tetherin-Restricting Activity on HIV-1 Particle Release Correlates with Localization of Vpu in the trans-Golgi Network. J Virol

49. PawliczekT

CrumpCM

2009 Herpes simplex virus type 1 production requires a functional ESCRT-III complex but is independent of TSG101 and ALIX expression. J Virol 83 11254 11264

50. JennerRG

MaillardK

CattiniN

WeissRA

BoshoffC

2003 Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile. Proc Natl Acad Sci U S A 100 10399 10404

51. WilsonSJ

TsaoEH

WebbBL

YeH

Dalton-GriffinL

2007 X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency. J Virol 81 13578 13586

52. AresteC

BlackbournDJ

2009 Modulation of the immune system by Kaposi's sarcoma-associated herpesvirus. Trends Microbiol 17 119 129

53. PowersC

DeFilippisV

MalouliD

FruhK

2008 Cytomegalovirus immune evasion. Curr Top Microbiol Immunol 325 333 359

54. ZuoJ

CurrinA

GriffinBD

Shannon-LoweC

ThomasWA

2009 The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation. PLoS Pathog 5 e1000255 doi:10.1371/journal.ppat.1000255

55. RobertsKL

SmithGL

2008 Vaccinia virus morphogenesis and dissemination. Trends Microbiol 16 472 479

56. EldeNC

ChildSJ

GeballeAP

MalikHS

2009 Protein kinase R reveals an evolutionary model for defeating viral mimicry. Nature 457 485 489

57. StameyFR

PatelMM

HollowayBP

PellettPE

2001 Quantitative, fluorogenic probe PCR assay for detection of human herpesvirus 8 DNA in clinical specimens. J Clin Microbiol 39 3537 3540

58. TowersGJ

StockholmD

Labrousse-NajburgV

CarlierF

DanosO

1999 One step screening of retroviral producer clones by real time quantitative PCR. J Gene Med 1 352 359

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2010 Číslo 4
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Získaná hemofilie - Povědomí o nemoci a její diagnostika
nový kurz

Eozinofilní granulomatóza s polyangiitidou
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa